Matricelf Initiates IND Enabling Efficacy Study Following Positive Preclinical Results in Spinal Cord Injury
TEL AVIV, Israel, June 22, 2026 /PRNewswire/ — Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing personalized engineered tissue implants... Read more.
RADCOM Launches Analytics Designer Module (ADM) for Real-Time, On-Demand Network Analytics
Powered by the new RADCOM RASE real-time, adaptive streaming engine, RADCOM ADM cuts analytics changes from months-long projects to same-day deployment TEL AVIV,... Read more.
Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer (“CMO”)
Dr. Selvaggi, a veteran immuno-oncology executive brings more than 30 years of oncology experience and a proven track record of advancing global clinical programs,... Read more.
Consello Expands UK Geopolitical Advisory with New Hire Wolfango Piccoli
NEW YORK, June 22, 2026 /PRNewswire/ — Consello, the leading global advisory and investing platform, today announced the appointment of Wolfango “Wolf”... Read more.
Watch a New Episode of Advancements on Saturday, July 27 at 8:00 PM ET
Get an inside look at how innovation is transforming operations in an increasingly tech-driven world. JUPITER, Fla., June 22, 2026 /PRNewswire/ — An upcoming... Read more.
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Colospan Ltd. (“Colospan”) provides Galmed Pharmaceuticals Ltd. (“Galmed”) (NASDAQ: GLMD) with a commercially ready product in the EU/Israel... Read more.
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Proposed acquisition adds a diverse pipeline of assets focused on elevating the standard of care for patients with dermatologic, respiratory and other related inflammatory... Read more.
DFI Debuts at Automate 2026 with Industrial Edge AI Platforms for Physical AI Deployment
TAIPEI, June 22, 2026 /PRNewswire/ — DFI, a global leader in embedded motherboards and industrial computers, makes its debut at Automate 2026 in Chicago, showcasing... Read more.
Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
Boehringer Ingelheim is committed to improving outcomes for people facing aggressive cancers where there are currently few treatment options DAREON®-Lung-1 and... Read more.
Rockwell Automation Technology Supports Modernization at New Heaven Hill Distillery
PlantPAx helps streamline operations at the state-of-the-art facility and enables future AI-driven optimization. MILWAUKEE, Wis., June 22, 2026 /PRNewswire/ —... Read more.